Market Overview:
Human embryonic stem cells are easily incorporated into a gene panel for tumor imaging. The DNA strands that comprise the genetic information code are present within the nucleus of each cell in the human body. However, as we all know sometimes there are mutations in these strands that can cause the genetic information coding to alter and thus lead to new diseases or even cancer. To keep track of which mutations have occurred in the genetic material of the gene panel can be used. The DNA strands from each person can be placed on this miniature panel which can then be used for the entire life of the individual. These small devices can also be used for the detection of other possible hereditary diseases and variants. In cases where one or more people in a family have been suspected of a certain disease or disorder, the results of these tests lookup can be compared with the DNA samples that are stored in the DNA banks.
Request a Sample Copy of the Research Report: https://www.coherentmarketinsights.com/insight/request-sample/4545
Competitive Landscape:
Major players operating in the global gene panel market include ArcherDx, GATC Biotech AG, Integrated DNA Technologies, F. Hoffmann-La Roche AG, Personalis, Novogene Corporation, GENEWIZ, Inc., Eurofins Scientific, QIAGEN, Agilent Technologies, Thermo Fisher Scientific, and Illumina, Inc.
Key Market Drivers:
The increasing prevalence of genetic testing labs in the world is the main factor that is expected to drive the growth of the global gene panel market. For instance, according to the European Federation of Biotechnology (EFB), there are around 751 laboratories performing genetic tests in Europe. The results of the gene panel can be immediately relayed to a research institute that has the capability to decode the variant that is being detected. This technology is one that can revolutionize the way that these diseases are detected and treated. It allows a genetic doctor to make the diagnosis much more quickly and also allows the patient to begin the treatments much earlier than otherwise. Increasing service launches by key market players are estimated to accelerate the growth of the global gene panel market.
Covid-19 Impact Analysis:
Increasing incidence of cardiovascular diseases, arthritis, and neurological diseases, which are associated with the COVID-19 infection positively impacted the growth of the global gene panel market. For instance, according to Our World in Data, the 7-day average of COVID cases in the world in November 2020, was around 544,230.
Get PDF Brochure with Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/4545
Key Takeaways:
The size of the global gene panel market is projected to increase at a CAGR of 19.2% to reach around US$ 2.95 billion by the year 2023, owing to the increasing rise of chronic diseases in the world. For instance, according to International Agency for Research on Cancer, in 2020 the number of cancer cases in the world was around US$ 19.3 million.
North America is expected to hold a major share of the global gene panel market, owing to the increasing prevalence of genetic labs in the region. For instance, according to Concert Genetics, there are around 70,000 active genetic testing units in the United States.
The Asia Pacific is estimated to witness high growth in the global gene panel market, owing to the increasing investments in genetic researches in the region along with the expansion of healthcare facilities in developing nations.
Reasons to Purchase this Report
• Current and future of global Gene Panel market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technique
- Market Snippet, By Design
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Porter’s Analysis
- Industry Trends
- Pipeline Analysis
- Key Highlights
- Epidemiology
- Pricing Analysis
- Reimbursement Scenario
- Regulatory Scenario
- Global Supply Chain Analysis
- Market Dynamics
- Global Gene Panel Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Gene Panel
- Impact of Covid-19 on the Gene Panel Market
- Global Gene Panel Market, By Technique, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Amplicon-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Hybridization-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Gene Panel Market, By Design, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Predesigned Gene Panels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Customized Gene Panels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Gene Panel Market, By Application, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Pharmacogenetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Diagnosis of Congenital Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cancer Risk Assessment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Gene Panel Market, By End User, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Hospital and Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Gene Panel Market, By Region, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2018 – 2028
- Regional Trends
- North America
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2028 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Technique, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Design, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2028 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017 – 2028 (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- BGI
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GENEWIZ, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GATC Biotech
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novogene Co., Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- QIAGEN
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Integrated DNA Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Illumina, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Agilent Technologies, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eurofins Scientific
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Hoffmann-La Roche Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Personalis Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GeneDx Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Invitae Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Thermo Fisher Scientific Inc.
- Analyst Views
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837